Found 10 matching trials
Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation
PHASE2The availability of antiretroviral therapy (cART) for HIV-1 infection has l...
Location
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV
PHASE2There is no cure for HIV infection. Antiretroviral therapy (ART) is widely ...
Location
Guys and St Thomas' NHS Trust
3BNC117 and 10-1074 in HIV-infected Individuals
PHASE1This is a phase 1b clinical trial to evaluate the safety, pharmacokinetics ...
Location
The Rockefeller University
Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI
PHASE1Participants will receive an infusion of both study drugs (3BNC117-LS and 1...
3BNC117 and 10-1074 in ART-treated Individuals
PHASE1The proposed study is a phase 1, open label, randomized study to evaluate t...
Location
Ragon Institute of MGH, MIT, and Harvard
Pausing Antiretroviral Treatment Under Structured Evaluation
PHASE1The main purpose of this study is to see if it is safe to give the study an...
Location
Gaborone CRS (12701)
Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
PHASE2RHIVIERA-02 trial is a placebo-controlled double-blinded two arm prospectiv...
Location
Hôpial Avicenne - SMIT
Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)
PHASE1This study will evaluate the safety, tolerability and innate immune mechani...
Location
Hospital of the University of Pennsylvania
3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption
PHASE2This study evaluates the effects of two infusions of 3BNC117 in preventing ...
Location
The Rockefeller University
3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)
PHASE1The proposed study is a phase 1, open label, single arm study to evaluate t...
Location
Weill Cornell Medicine, Cornell Clinical Trials Unit